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Objective: We evaluated quantitative EEG measures to determine a screening index to
discriminate Alzheimer’s disease (AD) patients from normal individuals.
Methods:Two groups of individuals older than 50 years, comprising a control group of 57
normal volunteers and a study group of 50 patients with probable AD, were compared.
EEG recordings were obtained from subjects in a wake state with eyes closed at rest for
30 min. Logistic regression analysis was conducted.
Results: Spectral potentials of the alpha and theta bands were computed for all electrodes
and the alpha/theta ratio calculated. Logistic regression of alpha/theta of the mean potential
of the C3 and O1 electrodes was carried out. A formula was calculated to aid the diagnosis
of AD yielding 76.4% sensitivity and 84.6% specificity for AD with an area under the ROC
curve of 0.92.
Conclusion: Logistic regression of alpha/theta of the spectrum of the mean potential of
EEG represents a good marker discriminating AD patients from normal controls.
Keywords: alpha, theta, Alzheimer’s disease, EEG, logistic regression
INTRODUCTION
Alzheimer’s disease (AD) is the most common form of dementia,
comprising 50–70% of all dementia cases. The burden of dementia
on the public health is increasing rapidly as our population ages
(Kukull and Bowen, 2002).
At present, no single neuropsychological test or complementary
exam is able to provide a reliable diagnosis of the disease in its early
stages (Nitrini et al., 2005). The inclusion of clinical neurophysio-
logical techniques, or more specifically, electroencephalography, in
diagnostic research protocols for AD is wholly justified given EEG’s
wide availability, low cost, and high sensitivity, allowing serial
exams and neurological evolution follow-up to be performed.
In addition to visual and spectral analyses, quantitative EEG
offers other research tools such as the alpha/theta ratio, an index
which shows the percentage of alpha versus theta spectral poten-
tial during wake state at rest. The normative value of the ratio in
healthy individuals is defined as ≥1. The study by Cibils (2002)
confirmed a lower alpha/theta ratio in patients with early and
moderate stages of AD, suggesting a pattern of activity for AD of
increased theta and decreased alpha.
However, the detection rate (sensitivity) of AD by qEEG lays
in the 60–90% range (among groups), depending on disease stage
and method used (Anderer et al., 1994; Besthorn et al., 1997). The
search for EEG-based methods able to discriminate normal indi-
viduals from demented patients remains a challenge. All of the
studies mentioned above provided the basis for the present study
(Anderer et al., 1994; Besthorn et al., 1997). Thus, our aim was
to determine a screening index to discriminate AD patients from
normal individuals for use in routine clinical practice to aid the
diagnosis of AD.
MATERIALS AND METHODS
SUBJECTS
The sample comprised 107 subjects (48 men and 59 women)
included in a comparative assessment involving two groups
(experimental group and control group). The experimental group
comprised 50 patients (19 men and 31 women) diagnosed with
probable AD, according to NINCDS-ADRDA criteria (McKhann
et al., 1984), of mild to moderate severity, based on DSM-IV R cri-
teria, and with scores on the MMSE of between 12 and 25 points
(Ordinance of The Health Care Secretariat/Brazilian Ministry of
Health, 2002). All patients were recruited from the Outpatient
Clinic of the Cognitive and Behavioral Neurology Group (GNCC)
of the Division of Clinical Neurology of the HCFMUSP and/or
from the CEREDIC of the HCFMUSP, and were submitted to rou-
tine outpatient assessment for diagnosing AD (Caramelli et al.,
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2011). The control group comprised normal subjects (29 men and
28 women) with scores on the MMSE≥26 and older than 50 years,
drawn from a database held by the neurophysiology service of the
Referral Center for Cognitive Disorders (CEREDIC) (Caramelli
et al., 1999).
Subjects with a history of diabetes mellitus, nephropathies, thy-
roidopathies, alcoholism, hepatopathies, pulmonary diseases, and
lack of vitamin B12 were excluded from the study.
STANDARD PROTOCOL APPROVALS, REGISTRATIONS, AND SUBJECTS
CONSENT
The Research Ethics Committee of the Faculty of Medicine of
University of São Paulo (FMUSP) approved all procedures (pro-
tocol number – 0895:09) and written informed consent was
obtained from all the subjects enrolled on the study (signed by
the participant or the guardian).
EEG RECORDING
Recordings during relaxed wakefulness were obtained from sub-
jects seated in a comfortable chair – to minimize muscular arti-
facts – with eyes closed during 30 min. Data acquisition was carried
out in an unlit room to reduce sensory interference. Briefly, 22
Ag/AgCl EEG electrodes were placed on the scalp placed in accor-
dance with norms of the Brazilian Society of Clinical Neurophys-
iology (International 10–20 system with bi-auricular referential
electrodes) for acquisition of the EEG (Anghinah et al., 2000).
Electrode impedances were closely monitored and kept below
3 kΩ. Data were acquired using the Neurosoft system with 32
channels, 12-bit processor at a sampling frequency of ≥200 sam-
ples/channel/s with filters for high frequencies of 70 Hz (low pass)
and low frequencies of 0.5 Hz (high pass).
An EEG technician and neurophysiologist were present during
the entire recording session to observe the behavioral state of the
patient and to monitor on-line for signal quality.
EEG DATA PROCESSING AND ANALYSIS
The data from baseline EEG were processed off-line using the
software of Neurosoft.
Possible sources of artifacts, such as blinking, muscle, and
saccade-related artifacts, were first identified by visual inspection
and subsequently by independent component analysis (ICA). Por-
tions of the EEG recording influenced by blinking-related artifacts
were removed by visual inspection as were components exhibiting
similar contamination on ICA.
A 40-s trace free of artifacts was selected (several 10- to 15-
s periods edited to produce a single 40-s file). The midline (Fz,
Cz, Pz, and Oz), auricular (isoelectric referential points), and Fp1;
Fp2 (due to eyebrow movement contamination) electrodes were
all excluded from the statistical analysis.
Spectral potentials of the alpha and theta bands were com-
puted separately for all electrodes and electroencephalograms.
Subsequently, the alpha/theta ratio for these spectral potentials
was calculated. Thus, a total of 20 electrodes common to the
whole sample were analyzed. Correlation Analysis and graphi-
cal analysis were carried out on the variables Maximum, Mean,
and Total Potential as well as Pathology. Logistic Regression
was performed for all the variables and the ROC curve was
obtained.
RESULTS
DEMOGRAPHIC CHARACTERISTICS
There were a total of 50 patients with probable AD and 57 normal
subjects. In the experimental group,age ranged from 52 to 89 years.
These subjects had a mean age of 75.2 (±8.08) years old. The level
of education of this group ranged from 0 to 13 years and the score
of MMSE ranged from 12 to 25. The patients were diagnosed with
regards to the severity of dementia by using the Clinical Dementia
Rating (CDR) scale (Morris, 1993). In the Alzheimer’s group, 34
patients had a CDR 1 (mild dementia) and 16 patients had a CDR
2 (moderate dementia). In the control group, age ranged from 57
to 86 years. These subjects had a mean age of 67.21 (±8.56) years
old. The level of education of this group ranged from 2 to 20 years
and the score of MMSE ranged from 26 to 30.
ANALYSES OF EEG VARIABLES
Among the variables studied, those that had greatest correlation
with Pathology (healthy group versus AD group) showed a neg-
ative association with 1% significance and only 1% probability
of error for: (a) alpha/theta ratio of maximum potential; (b)
alpha/theta ratio of mean potential; and (c) alpha/theta ratio of
total potential.
Detailed analysis revealed that individuals classified as AD
patients based on the alpha/theta ratio of Maximum, Mean,
and Total Potentials had lower values as a result of progressive
slowing of EEG waves. Conversely, among normal individuals,
these variables yielded higher values. Analysis of the variables
with only weak correlation showed a significant positive correla-
tion with Mean Frequency, albeit for few electrodes. For Asym-
metry, no significant correlation was detected for any of the
electrodes.
On overall statistical assessment, analysis of the correla-
tion matrix showed highest values between Pathology and
alpha/theta ratios for Maximum, Mean, and Total Potential,
whereas alpha/theta ratio of Maximum Potential exhibited high
variability, representing a disadvantage for use in patient classifi-
cation. Therefore, the optimal variable for discriminating normal
subjects from Alzheimer patients was Mean Potential, as depicted
in the graph below and on the linear distribution (Figure 1).
Logistic regression analysis results indicated which variables
best explained Pathology and yielded coefficient values for use in
a future index to aid diagnosis of AD patients. Logistic regres-
sion was performed using both one variable and two variables to
explain Pathology.
INDEX 1
On the model with one variable, the alpha/theta ratio of Mean
Potential for the O1 electrode (left) was chosen, explaining 77.6%
of Pathology. Based on these results, a simple and fast Index (Index
1 – Figure 2) was calculated for aiding AD diagnosis.
An alpha/theta ratio of mean potential of O1 electrode>1.42 is
deemed negative for AD; b-an alpha/theta ratio of mean potential
of O1 electrode ≤1.42 is deemed positive for AD.
Use of Index 1 yielded 83 correct diagnoses out of 107 cases, or
an overall rate of correct diagnosis of 77.6%.
Regarding sensitivity, among subjects classified as AD on the
test, the result was correct in 73% of cases. In terms of specificity
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FIGURE 1 | Red line: mean of total potential of alpha/theta ratio of
spectrum; yellow line: mean of maximum potential of alpha/theta
ratio of spectrum.
FIGURE 2 | Index 1 – using a single variable – the alpha/theta ratio of
the mean potential of the O1 electrode; a: sensitivity and b: specificity.
among subjects classified as Normal on the test, the result was
correct in 82% of cases.
INDEX 2
Based on previous result, another formula was calculated for aiding
AD diagnosis (Index 2 – Figure 3). The two variables chosen were
alpha/theta ratio of Mean Potential of C3 electrode and alpha/theta
ratio of Mean Potential of O1 electrode.
The Logistic regression analysis for the two variables model
returns three coefficients “a,” ”b,” and “c.”
The model can be used to calculate the probability of the sub-
ject belonging to the normal group (x = 0) or the pathological
group (x = 1). To compute the probability of belonging to the
pathological group we must evaluate the following equation:
P (x = 1) = e
(ax1+bx2+c)
1+ e(ax1+bx2+c) (1)
where:
P(x = 1) is the probability of belonging to the pathological group
FIGURE 3 | Index 2 – using a double variable – the alpha/theta ratio of
the mean potential of the O1 and C3 electrodes; a: sensitivity and b:
specificity.
a is the O1 electrode coefficient (a=−1.03844)
x1 is the alpha/theta ratio measured on the O1 electrode for the
studied patient
b is the C3 electrode coefficient (b=−1.55758)
x2 is the alpha/theta ratio measured on the C3 electrode for the
studied patient
c is the cut-off value c = 2.844023)
e is the natural logarithm base (e = 2.71828.)
The probability of belonging to the normal group can be
computed as:
P (x = 0) = 1− P (x = 1)
If P(x = 1) is >0.5 then P(x = 0) will be <0.5.
So we can write:
If P(x = 1)> 0.5 implies that the probability of belonging to
pathological group is greater than the probability of belonging to
the normal group.
But from Eq. 1 we can write:
If
e(ax1+bx2+c)
1+ e(ax1+bx2+c) > 0.5
implies that the probability of belonging to pathological group is
greater than the probability of belonging to the normal group.
Multiplying the both sides of the inequality by:
1+ e(ax1+bx2+c)
Results:
e(ax1+bx2+c) > 0.5
(
1+ e(ax1+bx2+c)
)
Multiplying the both sides of the inequality by two results:
2e(ax1+bx2+c) > 1+ e(ax1+bx2+c)
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Then, If
e(ax1+bx2+c) > 1
implies that the probability of belonging to pathological group is
greater than the probability of belonging to the normal group.
Applying the natural logarithm to the both sides of the
inequality:
ax1 + bx2 + c > 0
Replacing the coefficients:
a = −1.03844
b = −1.55758
c = 2.844023
We can rewrite:
−1.03844x1 − 1.55758x2 + 2.844023 > 0
If
1.03844x1 + 1.55758x2 < 2.844023
implies that the probability of belonging to pathological group is
greater than the probability of belonging to the normal group.
However these coefficients are difficult to remember.
If we multiply the both sides by a constant k > 0 the inequality
remains unaltered.
Particularly if k = 11.6 we have:
12.0459x1 + 18.0679x2 < 32.99066
But 12.0459 is very close to 12
and 18.0679 is very close to 18
and 32.99066 is very close 33
These numbers are easy to remember and the expression is
equivalent to the original equation. In fact, if:
12x1 + 18x2 < 33
implies that the probability of belonging to pathological group is
greater than the probability of belonging to the normal group.
Every positive integer multiple of these numbers will have
the same property. For example: The triple (24, 36, 66) also
works.
To calculate this index it is necessary to: (a) multiply
alpha/theta of mean potential of C3 electrode by 18; (b) multi-
ply alpha/theta of mean potential of O1 electrode by 12; and (c)
sum the two values. A result of <33 indicates dementia else no
dementia.
Regarding sensitivity, among subjects classified as AD on the
test, the result was correct in 76.4% of cases. In terms of speci-
ficity among subjects classified as Normal on the test, the result
was correct in 84.6% of cases.
The formula yielded 86 correct diagnoses out of 107 cases,
or an overall rate of correct diagnosis of 80.4%. These variables
explained 80.4% of Pathology, 2.8% higher than the model con-
taining only one variable which yielded 77.6% correct diagnosis.
DISCUSSION
Although numerous studies in the literature have shown correla-
tion of progressive slowing of EEG waves with AD evolution (Bren-
ner et al., 1988; Watanabe et al., 1993; Anderer et al., 1994; Claus
et al., 1998; Babiloni et al., 2004) and reported lower alpha/theta
ratios in AD (Cibils, 2002; Reis and Fonseca, 2010), they were based
on groups of patients and not on healthy individuals “per se” and
also failed to quantify a mean numeric value for the ratio in a
group of normal individuals.
Our results showed that it is possible to discriminate AD
patients from normal individuals using a mathematical analysis
tools in combination with EEG. A cut-off index distinguishing
between these two samples with 76.4% sensitivity and 84.6%
specificity was determined. These findings discriminated among
individuals as well as between the AD and control groups, what
represents advancement.
In the present study, a cut-off value of 33 for logistic regres-
sion of the alpha/theta ratio was determined. Thus, individuals
with results≥33, have a high electroencephalographic probability
of being normal, whereas for values lower than 33 there is a high
probability of the subject belonging to the AD group.
Like most current methods of diagnosis, even more in the case
of functional method, the correlation was made and is significant
compared to the clinical findings. The gold standard for AD’s diag-
nosis is still pathological. Therefore, the method presented in here
is not a definitive tool but an instrument as an aid in diagnosis in
search of a non-invasive biomarker.
These results numerically corroborate findings in the literature,
i.e., that among normal individuals there is a predominance of
posterior alpha activity over slow activity (theta), while this pre-
dominance diminishes with slowing of the trace and increased
theta activity relative to lower alpha activity. The anatomo-
physiological substrate strongly supporting these findings is that
of the cholinergic theory for AD.
Changes in the cholinergic system were studied in normal
aging and in AD (Schliebs and Arendt, 2011) leading to evidence
of severe deficits in pre-synaptic cholinergic markers in cerebral
cortex of AD patients (Davies and Maloney, 1976). This theory
was corroborated by studies in the literature showing correlation
between cholinergic hypofunction and cognitive deficits, leading
to the cholinergic hypothesis to explain decline in memory among
normal elderly and in AD (Mufson et al., 2008).
Patients with AD have a significantly less complex EEG signal
than normal individuals of similar age. This finding can be associ-
ated with impaired processing in brains with AD, characterized by
a loss of modulation and complexity of brain rhythms, reflecting
impaired neurotransmission. The majority of studies on EEG in
AD have shown marked decline in coherence of the alpha band,
which have been associated with increased genetic risk of ApoE,
hypothetically related to impaired cholinergic neurotransmission
(Lizio et al., 2011).
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The increased relative theta potential described is not new in the
literature, it is in fact expected (Bennett et al., 2004). From a func-
tional standpoint, the increased relative potential of the theta band
is a sign of medial hippocampal activation while the decrease in
alpha activity correlates with involvement of the corticothalamo-
cortical retroactivation mechanism (Colom, 2006).
These literature findings of thalamic dysfunction in cortical
connectivity highlight the need to scrutinize the information
which advances in mathematics and computation can derive from
electroencephalographic records. It is known that the thalamus,
together with the cuneus and precuneus, are the main sources of
alpha activity of patients at rest (Cantero et al., 2009). Slowing of
the alpha rhythm and increasing of theta activity can occur in a
broad array of neurological and psychiatric disorders (Llinás et al.,
1999).
Based on these postulations in the literature, we cannot categor-
ically affirm that our findings confirm a definitive marker for dis-
criminating AD patients from normal individuals. Nevertheless,
this index of logistic regression for the alpha/theta ratio can be used
to indicate a watershed between normality and individuals with
pathologies that reflect disturbances in brain function through the
non-invasive EEG exam.
CONCLUSION
To summarize, logistic regression of the alpha/theta ratio of the
spectrum of the mean potential of EEG constitutes a valuable
marker for discriminating AD patients from healthy controls,
where individuals with an index ≥33 are considered electroen-
cephalographically normal.
There is no established markers for the EEG, and more than
having a marker for AD, the first point would have a marker for
normal, which would be a great starting point for future increment
methodology.
Undoubtedly, our findings regarding the pathology already has
its importance by itself, but we believe that the biggest break-
through refers to the existence of a normality cut-off, statistically
robust, which had not yet in quantitative EEG.
Further investigations are needed to confirm these findings and
render this EEG analysis tool more robust, hopefully promoting
its future use in routine practice.
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